ENSC - CONSENSUS CO - Ensysce Biosciences

This daily price chart for Ensysce Biosciences (ENSC) illustrates the asset's price action, with its value reaching 8.22. The business automates the creation of safe analgesics through AI and robotics to eliminate routine tasks. Ensysce Biosciences (ENSC) is outperforming the market by developing treatments for opioid addiction that feature intestinal activation. The company's environmental development strategy is based on a closed-loop water system and the minimization of the carbon footprint during production.

The consensus forecast aggregates independent expert estimates, filtering out market noise and allowing investors to identify asset undervaluation through the gap between the current price and the average target. By analyzing the consensus target history for Ensysce Biosciences (ENSC), one can assess the extent to which the market prices in the patent protection of TAAP and MPAR technologies and high FDA barriers to entry into the fair value of the shares.